Don O’Sullivan
About Don O’Sullivan
Don O’Sullivan is the Chief Business Officer at AsherBio, known for his extensive experience in oncology partnering and corporate development in the biotech sector.
Don O’Sullivan Chief Business Officer at AsherBio
Don O’Sullivan currently holds the position of Chief Business Officer at AsherBio. He chose to join AsherBio due to the compelling opportunity to work with a talented team and leverage his extensive experience to aid in advancing Asher’s potentially transformative cis-targeted immunotherapies to patients.
Don O’Sullivan Past Experience at Roche and Genentech
Before joining AsherBio, Don O’Sullivan served as Vice President and Global Head of Oncology Partnering at Roche and Genentech. During his tenure, he held various roles of increasing responsibility over nearly 12 years. His work included leading the partnering efforts for Genentech's gRED Immunology and Infectious Disease R&D groups, showcasing his extensive expertise in the biotechnology and pharmaceutical industries.
Don O’Sullivan Professional Background at Genzyme
Don O’Sullivan also gained significant professional experience during his three years at Genzyme. He was part of the Corporate Development group, further diversifying his skill set and understanding of the biotech sector. This role at Genzyme contributed to his comprehensive background in corporate development and strategic partnering.
Don O’Sullivan Education and Academic Credentials
Don O’Sullivan has a robust academic background. He earned a Ph.D. in Molecular Biology from the University of Cambridge, reinforcing his deep scientific expertise. Additionally, he obtained an MBA from Wharton, University of Pennsylvania, which equipped him with essential business acumen. Earlier in his academic journey, he completed a B.Sc. in Biochemistry from Imperial College, London, laying a solid foundation in the life sciences.